Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Asthma

  Free Subscription


Articles published in Pulm Pharmacol Ther

Retrieve available abstracts of 29 articles:
HTML format
Text format



Single Articles


    February 2017
  1. BJERMER L, Gauvreau GM, Postma DS, O'Byrne PM, et al
    Methacholine challenge tests to demonstrate therapeutic equivalence of terbutaline sulfate via different Turbuhaler(R) devices in patients with mild to moderate asthma: Appraisal of a four-way crossover design.
    Pulm Pharmacol Ther. 2017 Feb 20. pii: S1094-5539(16)30155.
    PubMed     Text format     Abstract available


  2. AMMARI WG, Al-Hyari N, Obeidat N, Khater M, et al
    Mastery of pMDI technique, asthma control and quality-of-life of children with asthma: A randomized controlled study comparing two inhaler technique training approaches.
    Pulm Pharmacol Ther. 2017 Feb 16. pii: S1094-5539(16)30084.
    PubMed     Text format     Abstract available


    January 2017
  3. BRUSSELLE G, Germinaro M, Weiss S, Zangrilli J, et al
    Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils.
    Pulm Pharmacol Ther. 2017 Jan 31. pii: S1094-5539(17)30035.
    PubMed     Text format     Abstract available


  4. BIANCO A, Nigro E, Monaco ML, Matera MG, et al
    The burden of obesity in asthma and COPD: Role of adiponectin.
    Pulm Pharmacol Ther. 2017 Jan 20. pii: S1094-5539(16)30148.
    PubMed     Text format     Abstract available


  5. COONEY L, McBride A, Lilley A, Sinha I, et al
    Using pharmacokinetic modelling to improve prescribing practices of intravenous aminophylline in childhood asthma exacerbations.
    Pulm Pharmacol Ther. 2017 Jan 17. pii: S1094-5539(16)30128.
    PubMed     Text format     Abstract available


  6. LIU Y, Zhang H, Ni R, Jia WQ, et al
    IL-4R suppresses airway inflammation in bronchial asthma by inhibiting the IL-4/STAT6 pathway.
    Pulm Pharmacol Ther. 2017 Jan 13. pii: S1094-5539(16)30110.
    PubMed     Text format     Abstract available


    December 2016
  7. SHARMA A, Kerstjens HA, Aalbers R, Moroni-Zentgraf P, et al
    Pharmacokinetics of tiotropium administered by Respimat(R) in asthma patients: Analysis of pooled data from phase II and III clinical trials.
    Pulm Pharmacol Ther. 2016 Dec 27. pii: S1094-5539(16)30127.
    PubMed     Text format     Abstract available


    November 2016
  8. YOSHIDA M, Kaneko Y, Ishimatsu A, Komori M, et al
    Effects of tiotropium on lung function in current smokers and never smokers with bronchial asthma.
    Pulm Pharmacol Ther. 2016 Nov 22. pii: S1094-5539(16)30169.
    PubMed     Text format     Abstract available


    September 2016
  9. SINGH J, Shah R, Singh D
    Inundation of asthma target research: Untangling asthma riddles.
    Pulm Pharmacol Ther. 2016 Sep 22. pii: S1094-5539(16)30109.
    PubMed     Text format     Abstract available


  10. LING ZG, Wu YB, Kong JL, Tang ZM, et al
    Lack of efficacy of nebulized magnesium sulfate in treating adult asthma: A meta-analysis of randomized controlled trials.
    Pulm Pharmacol Ther. 2016 Sep 17. pii: S1094-5539(16)30102.
    PubMed     Text format     Abstract available


  11. PYASI K, Tufvesson E, Moitra S
    Evaluating the role of leukotriene-modifying drugs in asthma management: Are their benefits 'losing in translation'?
    Pulm Pharmacol Ther. 2016 Sep 17. pii: S1094-5539(16)30100.
    PubMed     Text format     Abstract available


  12. CHAN R, Sousa AR, Mallett S, Hynds P, et al
    Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthma.
    Pulm Pharmacol Ther. 2016 Sep 3. pii: S1094-5539(16)30094.
    PubMed     Text format     Abstract available


    July 2016
  13. SULAIMAN I, Woei LC, Liong SH, Stanslas J, et al
    Molecularly targeted therapies for asthma: Current development, challenges and potential clinical translation.
    Pulm Pharmacol Ther. 2016 Jul 21. pii: S1094-5539(16)30056.
    PubMed     Text format     Abstract available


  14. PELAIA G, Vatrella A, Busceti MT, Fabiano F, et al
    Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma.
    Pulm Pharmacol Ther. 2016 Jul 2. pii: S1094-5539(16)30052.
    PubMed     Text format     Abstract available


    June 2016
  15. ERPENBECK VJ, Popov TA, Miller D, Weinstein SF, et al
    The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma.
    Pulm Pharmacol Ther. 2016 Jun 21. pii: S1094-5539(16)30044.
    PubMed     Text format     Abstract available


    May 2016
  16. CIOLKOWSKI J, Mazurek H, Hydzik P, Stasiowska B, et al
    Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.
    Pulm Pharmacol Ther. 2016 May 24. pii: S1094-5539(16)30034.
    PubMed     Text format     Abstract available


    March 2016
  17. OHBAYASHI H, Setoguchi Y, Fukuchi Y, Shibata K, et al
    Pharmacological effects of lysozyme on COPD and bronchial asthma with sputum: a randomized, placebo-controlled, small cohort, cross-over study.
    Pulm Pharmacol Ther. 2016 Mar 4. pii: S1094-5539(16)30011.
    PubMed     Text format     Abstract available


    February 2016
  18. HOZAWA S, Terada M, Haruta Y, Hozawa M, et al
    Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
    Pulm Pharmacol Ther. 2016 Feb 2. pii: S1094-5539(16)30005.
    PubMed     Text format     Abstract available


    January 2016
  19. KANG JY, Jo MR, Kang HH, Kim SK, et al
    Long-term azithromycin ameliorates not only airway inflammation but also remodeling in a murine model of chronic asthma.
    Pulm Pharmacol Ther. 2016 Jan 8. pii: S1094-5539(15)30018.
    PubMed     Text format     Abstract available


    November 2015
  20. CHERVINSKY P, Meltzer EO, Busse W, Ohta K, et al
    Roflumilast for asthma: Safety findings from a pooled analysis of ten clinical studies.
    Pulm Pharmacol Ther. 2015 Nov 20. pii: S1094-5539(15)30014.
    PubMed     Text format     Abstract available


    June 2015
  21. SIBILA O, Soto-Gomez N, Restrepo MI
    The risk and outcomes of pneumonia in patients on inhaled corticosteroids.
    Pulm Pharmacol Ther. 2015;32:130-6.
    PubMed     Text format     Abstract available


  22. PACE E, Di Sano C, Ferraro M, Bruno A, et al
    Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics.
    Pulm Pharmacol Ther. 2015;32:93-100.
    PubMed     Text format     Abstract available


    April 2015
  23. ORLANDI A, Calzetta L, Doldo E, Tarquini C, et al
    Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells.
    Pulm Pharmacol Ther. 2015;31:51-4.
    PubMed     Text format     Abstract available


  24. THOMSON NC, Charron CE, Chaudhuri R, Spears M, et al
    Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma.
    Pulm Pharmacol Ther. 2015;31:1-8.
    PubMed     Text format     Abstract available


  25. NOVELLI F, Latorre M, Vergura L, Caiaffa MF, et al
    Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy.
    Pulm Pharmacol Ther. 2015;31:123-9.
    PubMed     Text format     Abstract available


  26. BRUSSELLE GG, Blasi F
    Risk of a biased assessment of the evidence when limiting literature searches to the English language: macrolides in asthma as an illustrative example.
    Pulm Pharmacol Ther. 2015;31:109-10.
    PubMed     Text format    


  27. TONG X, Guo T, Liu S, Peng S, et al
    Macrolide antibiotics for treatment of asthma in adults: a meta-analysis of 18 randomized controlled clinical studies.
    Pulm Pharmacol Ther. 2015;31:99-108.
    PubMed     Text format     Abstract available


  28. KIRSTEN AM, Watz H, Brindicci C, Piccinno A, et al
    Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.
    Pulm Pharmacol Ther. 2015;31:79-84.
    PubMed     Text format     Abstract available


    February 2015
  29. GOVONI M, Piccinno A, Lucci G, Poli G, et al
    The systemic exposure to inhaled beclometasone/formoterol pMDI with valved holding chamber is independent of age and body size.
    Pulm Pharmacol Ther. 2015;30:102-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: